Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,148 | 6,502 | 5,394 | 21,403 | 38,453 |
| Marketable Securities | 35,240 | 15,478 | 20,726 | 16,472 | 3,720 |
| Receivables | 7,710 | 7,333 | 8,511 | 7,425 | 6,933 |
| Inventories | 18,147 | 16,473 | 15,088 | 14,052 | 13,252 |
| TOTAL | $122,267 | $49,532 | $53,061 | $62,420 | $65,477 |
| Non-Current Assets | |||||
| PPE Net | 2,994 | 2,954 | 3,033 | 2,987 | 3,147 |
| Investments And Advances | 6,486 | 7,858 | 9,187 | 1,494 | 1,494 |
| Intangibles | 28,749 | 28,094 | 28,542 | 29,239 | 29,945 |
| Other Non-Current Assets | 146 | 139 | 140 | 139 | 140 |
| TOTAL | $38,374 | $39,045 | $40,903 | $33,859 | $34,726 |
| Total Assets | $160,641 | $88,576 | $93,963 | $96,279 | $100,203 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,503 | 4,523 | 5,338 | 4,818 | 4,596 |
| Accrued Expenses | 2,178 | 4,969 | 4,226 | 4,059 | 3,197 |
| TOTAL | $7,681 | $9,492 | $9,564 | $8,876 | $7,793 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 263 | 275 | N/A |
| Other Non-Current Liabilities | 230 | 242 | 0 | 0 | 293 |
| TOTAL | $1,909 | $1,937 | $1,941 | $2,020 | $1,971 |
| Total Liabilities | $9,590 | $11,428 | $11,505 | $10,896 | $9,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,182 | 25,132 | 17,285 | 17,264 | 16,977 |
| Common Shares | 252 | 174 | 173 | 172 | 168 |
| Retained earnings | -74,441 | -64,171 | -58,745 | -53,796 | -46,452 |
| Other shareholders' equity | 502 | 1,081 | 1,979 | 1,371 | 1,540 |
| TOTAL | $151,051 | $77,148 | $82,459 | $85,383 | $90,439 |
| Total Liabilities And Equity | $160,641 | $88,576 | $93,963 | $96,279 | $100,203 |